That is the whole story, start to finish: a stubborn idea from 1975, a researcher who spent his life on it, a compound that healed everything in rats, a human trial whose result nobody saw for twenty years, a molecule no company can own so no company will finish testing, and a stack of the most basic questions is it safe, at what dose, made by whom, and how does it actually work that still have no answers
In these cases, oral supplements may not be effectively absorbed, making B12 injections a more reliable treatment option
While there is some animal data and limited human research supporting its potential use case, its safety and efficacy profile is still not well-understood
What you are actually choosing between in the lab If your research question is GLP-1 receptor pharmacology in isolation, semaglutide is the deepest-validated reference agonist
Its extensive clinical trial history (14+ RCTs in stroke alone), approval in 44+ countries, and multi-modal mechanism have generated substantial discussion in research communities